Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL, sure.
Let's see how that narrative helps MYDX.
BTW, the 10-Q says "matter" not dismissed, not "case" or "settlement." Big difference.
Last 10-Q also says the pen is coming out Q1 2019. LOL
It would be AWESOME to see this go back to the courts. Won't happen though because the last thing Daniel Yazbeck wants to do is go under oath in a deposition or cross-examination.
Judge overruled three of the eight, hence why Yazbeck had to settle his $29,000,000.00 lawsuit for $5K, and to avoid answering questions under oath.
Frivolous?..Judge OVERRULED the DEMURRER...
Cool....Yazbeck testifying under oath would be very revealing.
I hope so
LOL, sure.
Let's see how that narrative helps MYDX.
BTW, the 10-Q says "matter" not dismissed, not "case" or "settlement." Big difference.
Last 10-Q also says the pen is coming out Q1 2019. LOL
It would be AWESOME to see this go back to the courts. Won't happen though because the last thing Daniel Yazbeck wants to do is go under oath in a deposition or cross-examination.
We all know there's no case number because the judge granted MYDX's motion to dismiss the case last year.
What's the court case number?
Business was interfered with publicly...hence the filed complaint to the court.
Interesting, thanks for the information.
Do you think Yaz is going to keep squeezing MYDX or is he going to sell the MYDX ticker symbol, like he bought Brista?
Likely one of the reasons why the company diluted nearly half a billion MYDX shares in October alone.
Between the golden parachute his buddies wrote him ($410k)
Daniel R. Yazbeck, Chief Executive Officer
On October 15, 2014, CDx, Inc. entered into a five year employment agreement with Daniel R. Yazbeck. The employment agreement provides that Mr. Yazbeck shall serve as the CDx Chief Executive Officer or such other title or position as may be designated from time to time by the CDx board of directors. The employment agreement can be terminated pursuant to written notification by either CDx or Mr. Yazbeck, which notification may occur at any time for any reason. Mr. Yazbeck’s initial base salary is $180,000 per year, subject to periodic review by the CDx board of directors and may be increased in the discretion of CDx.
Under the terms of the employment agreement, Mr. Yazbeck is also eligible to participate in all group term life insurance plans, group health plans, accidental death and dismemberment plans and short-term disability programs and other perquisites which are made available to the CDx executives and for which Mr. Yazbeck qualifies. Additionally, Mr. Yazbeck is entitled to be reimbursed for supplemental insurance products including life insurance at a cost of up to an additional $15,000 per year. CDx also provides a leased vehicle with operating expenses, not to exceed $800 per month, which CDx commenced paying in March 2015.
Under the terms of the employment agreement, should CDx terminate Mr. Yazbeck’s employment other than for cause during the first 5 years of the employment agreement, or should Mr. Yazbeck resign for good reason, CDx shall have no further obligation under the employment agreement, except that CDx will continue to pay Mr. Yazbeck’s base salary for a two year period, (less, if applicable, any long-term disability payments) and the Target Bonus (as defined below) for a one year period following termination of Mr. Yazbeck’s employment on the normal payroll dates, and in addition one hundred percent (100%) of Mr. Yazbeck’s then-outstanding unvested stock options shall immediately vest.
The employment agreement provides that for each fiscal year during the employment agreement, Mr. Yazbeck shall be eligible for an incentive bonus. For each full fiscal year of employment, Mr. Yazbeck shall be eligible for an incentive bonus of up to one hundred percent (100%) of his annual base salary and his performance objectives shall be set such that one hundred percent (100%) completion of his objectives shall entitle him to at least seventy-five percent (75%) of the bonus (the “Target Bonus”). During the first year of employment Mr. Yazbeck shall be eligible for the bonus plan as outlined in the employment agreement. After the first year, the bonus amount will be based on the following factors: (1) the financial performance of CDx as determined and measured by CDx’s board of directors, and (2) Mr. Yazbeck’s achievement of management targets and goals as set by CDx. The bonus amount is intended to reward contribution to CDx’s performance over an entire fiscal year, and on the basis of continuing, cumulative contribution, and consequently will be paid only if Mr. Yazbeck is employed and in good standing at the time of bonus payments, which will occur each quarter. CDx accrued a $45,000 bonus for Mr. Yazbeck in compliance with the terms of his target bonus milestones for completion of a working prototype. The bonus was paid in March 2015.
On November 10, 2018, the Company entered into a settlement agreement and general release (the “Settlement and Release Agreement”) with Mr. Yazbeck whereby Mr. Yazbeck agreed to grant the Company an extension to repay certain obligations in the aggregate amount of $410,689.99 currently due and owing to Mr. Yazbeck pursuant to his employment agreement with the Company entered into on October 15, 2014 (the “Settled Claims”). As consideration for extending the date for the Company to repay the Settled Claims to January 1, 2020, the Company agreed to extend the expiration date of warrant to purchase shares of Common Stock previously issued to an entity controlled by Mr. Yazbeck (the “YCIG Warrant”) to November 10, 2022 and to revise certain other provisions of the YCIG Warrant. As of April 23, 2019, the revised warrant had not yet been issued to Mr. Yazbeck.
Daaaammmnnn, anybody who "has millions" of MYDX shares, implying having at least 2M of them. And if they are in at .0185, that's a minimum of $37,000 invested to MYDX, and by today's open, down 99.19% and is now worth $299.70.
OUCH!
KUSHCO HOLDINGS EXPANDS CBD FOOTPRINT WITH LAUNCH OF NEW HEMP TRADING BUSINESS
Maybe this new development was one of the reasons they diluted harder in 2019.
Invest $10,000 in MYDX when the SP was $3.00? That investment is now worth one dollar.
That’s not resiliency, that’s calculating losses for tax purposes.
LOL, the company doesn't disclose when it's being sued (such as the Peatross case), nor did it ever disclose the several other lawsuits it either lost or was forced to settle.
Why would it do so with the SEC?
So there is a settlement for a lawsuit MYDX filed....to a case the court says is dismissed.
And MYDX acknowledges the settlement terms were met in the form of $5,000.
And the company still says the matter hasn’t been dismissed (but the case has), but does not disclose what that means.
Yet the company petitioned the court to dismiss the lawsuit.
LOL....wonder if MYDX had to pay Dewald’s legal fees and hasn’t done it yet. Company has a rich history of not paying bills and being taken to court.
Oh is that the case that MYDX filed for dismissal last year?
Funny how MYDX was seeking $29,000,000.00 and ended up with $5K. Even more funny was how the company had to settle for that to a dude with, according to the court website, no legal representation.
Wonder how much MYDX had to pay Jerome Dewald for his legal defense from a lousy lawsuit.
Thanks for the reminder.
Yup, La Ley will get to the bottom of MYDX.
Settlement to what? I was told there was no court case for MYDX to settle.
Then what is being settled if there is no court case?
What’s the case number that hasn’t been dismissed?
LOL, MYDX has been saying products are “coming soon” since 2015.
Company has been sued by more vendors than the number of products it has actually released.
It’s not just the jury, it’s how a lot of very specific questions would be asked in a deposition and in cross-examination, both of which would have Yazbeck under oath.
A LOT of MYDX dirty laundry has the potential for coming out. I’m sure someone would be happy to send the transcripts to the SEC.
Defendant Yazbeck should be ready, because Jessica Peatross already paid the jury fees in the case against MYDX.
April 17, 2020. Case number 37-2018-00055626-CU-CO-NC
Is this before or after the pen release the company has twice affirmed will be coming out Q1 2019?
Or 2H2017?
Then Q1 2018?
Then Q3 2018?
Sorry, all these release dates the company issues seem to blend together.
Yazbuck still has at least 2B restricted, I highly doubt he’s going to leave $500K on the table.
They should have said that in the PR, because in tandem with plateaued numbers it looks bad.
LOL, I’m still waiting for the Israeli Clinical Trial results the company was supposed to provide Q2.
Q2 2018 that is.
Planet monthly reports ending.
Source
Planet 13 has provided monthly traffic updates for the first year of operations. Going forward, Planet 13 will provide traffic updates as part of its quarterly Management Discussion and Analysis.
That has to make MYDX Shareholders rather Salty.
The MYDX Pen has been “coming soon” since April 2017.
OrganaDX has been “coming soon” since 2015.
And MYDX is trading in the quads now.
Well, he owes AQS $15K a month though March 2021.
Still owes Cedar Business Services $60K.
Who knows if he's still paying Arrow the monthly payments.
MYDX doesn't have enough shares for the TRD settlement.
Nor does the company have enough shares for the BCI settlement.
And how many toxic loans in the past year.....eight?
Yazie got a quick $13,772 for his ATM trip first thing this morning..
In connection with his appointment as interim Chief Executive Officer and interim Chief Financial Officer, the Company agreed to pay Mr. Yazbeck a salary of $10,000 per month, or $120,000 per year, with no additional benefits at this time.
On November 10, 2018, the Company entered into a settlement agreement and general release (the “Settlement and Release Agreement”) with Mr. Yazbeck whereby Mr. Yazbeck agreed to grant the Company an extension to repay certain obligations in the aggregate amount of $410,689.99 currently due and owing to Mr. Yazbeck pursuant to his employment agreement with the Company entered into on October 15, 2014 (the “Settled Claims”). As consideration for extending the date for the Company to repay the Settled Claims to January 1, 2020, the Company agreed to extend the expiration date of warrant to purchase shares of Common Stock previously issued to an entity controlled by Mr. Yazbeck (the “YCIG Warrant”) to November 10, 2022 and to revise certain other provisions of the YCIG Warrant. As of April 23, 2019, the revised warrant had not yet been issued to Mr. Yazbeck.
Quads traded last week already, there are just more trips to the MYDX ATM happening in the quads.
Yazbeck has said repeatedly in the financials for the past few years he needs to dilute in order to keep the company going.
That’s exactly what he doing.
What’s the part that’s not understood?
Planet targets tourists and charges a premium, their prices are not geared towards local regulars.
That's Planet's bread and butter, drawing in the tourists.
Initial business plan budgeted for an average $75 ticket per converted, average ticket hovering around $90, which is good.
So?
Those numbers get larger when the OS goes from 22M to 5.2B.
Years of micro-analysis of Level II have gotten MYDX from $3.00 to $0.0001.
Yazbeck has made millions off MYDX, where shareholders have gotten screwed.
The MYDX OS exploded from 22M to 5.2B on Daniel Yazbeck’s watch.
That is just too cute for Yazbeck to do. Years-old data, even IF it exists, doesn’t mean squat when, as Yazbeck says, “you’re always gonna need the lab.”
It wasn’t the first time either. Same text was on the 10-K released on April 25, 2019.